Trials / Completed
CompletedNCT00324402
Plasma Brain Natriuretic Peptide Levels in Pregnancy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- Oklahoma State University Center for Health Sciences · Academic / Other
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the maternal blood concentrations of brain natriuretic peptide (BNP) during the second and third trimesters of a normal pregnancy. We will attempt to define a normal range for pregnancy and any outliers that may serve as markers for abnormal cardiovascular physiology.
Detailed description
The brain natriuretic peptide (BNP) is a useful marker for volume overload, increased filling pressures and stretching of the myocardium. The current literature contains limited and unreliable information regarding normal BNP values in pregnancy. After baseline echocardiogram to detect individuals with asymptomatic structural defects, the participants will submit to 3 blood draws during the second and third trimester and at delivery to determine normal pregnancy values.
Conditions
Timeline
- Start date
- 2006-08-01
- Completion
- 2008-06-01
- First posted
- 2006-05-11
- Last updated
- 2020-10-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00324402. Inclusion in this directory is not an endorsement.